Arsenale Bioyards is building a new industrial infrastructure that integrates hardware, data, and AI into a seamless end‑to‑end biomanufacturing system—from lab‑scale organism design to industrial‑scale production. Its platform incorporates micro‑scale precision fermentation reactors, real‑time data capture, and Design@Scale, a proprietary AI platform that predicts industrial-scale outcomes from lab-scale data and continuously refines process performance across every fermentation run.

Amphasys will provide the cell analytical part based on its proprietary impedance flow cytometry technology which is renowned for high‑precision, label‑free characterization of all types of cells and which allows in-process measurements. This real-time, high-content cell information will be integrated with Arsenale’s AI‑driven bioreactor and data platform to create the first platform linking cell‑level performance directly to industrial‑scale bioprocess outcomes.

The companies anticipate that the combined platform will significantly reduce development cycles, improve process predictability, and remove the trial-and-error that still defines scale-up in biomanufacturing today. The JDA underscores both companies’ commitment to accelerating the global transition toward sustainable bioproduction.

Dr. Marcel Ottiger, CEO of Amphasys, says, “We are excited to merge our cell analytical technology with Arsenale’s revolutionary biomanufacturing platform, creating a new standard for data‑driven bioprocess development. High‑resolution cellular insights combined with next‑generation, AI‑driven biomanufacturing infrastructure creates a powerful foundation for faster, more predictable, and scalable bioproduction.”

Massimo Portincaso, CEO & Co‑Founder of Arsenale Bioyard, comments, "We designed our platform around one conviction: hardware exists to generate data, and data is what makes the AI work. The bottleneck in biomanufacturing has never been computing power, it's been the absence of high-resolution information at the cellular level, at the moment decisions get made. Amphasys solves exactly that. Their cell analysis feeds Design@Scale with the signal it needs to predict outcomes and improve with every run."